ESC Professional Premium Access

Including measures of chronic kidney disease to improve cardiovascular risk prediction by SCORE2 and SCORE2-OP

Topic: Cardiovascular Risk Assessment

Congress Presentation

About the speaker

Mr Steven Hageman

University Medical Center Utrecht, Utrecht (Netherlands (The))
3 presentations
0 follower

7 more presentations in this session

Potential impact of replacing SCORE with SCORE-2 on risk classification and statin eligibility - a coronary calcium score correlation study

Speaker: Miss M. Paiva (Lisbon, PT)


Associations of SCORE2, circulating cardiovascular biomarkers and carotid intima-media-thickness in a population-based cohort

Speaker: Doctor B. Toprak (Hamburg, DE)


Comparison between the European SCORE and the updated SCORE2 for cardiovascular outcomes

Speaker: Doctor M. Temtem (Funchal, PT)


Distribution of cardiovascular disease risk according to SCORE2 and potential need for cholesterol and blood pressure lowering therapy in apparently healthy middle-aged individuals

Speaker: Doctor A. Yari (Stockholm, SE)


In a large dataset of primary care patients, use of CHA2DS2-VA score leads to almost universal recommendation for anticoagulation in those aged 65 years and over with atrial fibrillation

Speaker: Doctor J. Orchard (Sydney, AU)


Access the full session

Cardiovascular risk assessment and scores

Speakers: Mr S. Hageman, Miss M. Paiva, Doctor B. Toprak, Doctor M. Temtem, Doctor A. Yari...

About the event


ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb